The Leadership Team at Editas Medicine drives the strategic direction and operational excellence of the company, overseeing critical functions such as research and development, legal compliance, commercial strategy, and clinical operations. This diverse group of executives collaborates to advance innovative genome editing therapies, ensure regulatory compliance, and foster partnerships, all while focusing on delivering transformative medicines for patients with genetically-defined diseases.
Caren Deardorf
EVP & Chief Commercial & Strat...
Charlene Stern
EVP & General Counsel
Damien Grierson
Senior Vice President, Deputy ...
Gary Sclar
VP & Counsel, Licensing And Tr...
Gilmore O’Neill
President & CEO
Linda C. Burkly
EVP & Chief Scientific Officer
Linea Aspesi
EVP & CPO
Steven Wolk
Vice President Of Chemistry & ...
Tamara Monesmith
Senior Vice President, Technic...
Tanya Teslovich
Vice President, Head Of Geneti...
View all